Résultats de la recherche - 75 results
Validation of a rapid SARS-CoV-2 antibody test in general practice
Stefan; Van den Bruel, Ann; I Desombere; Van Damme, Pierre; Goossens, Herman; Buret, Laetitia; Duysburgh, Els; Coenen, Samuel Source: BMJ Open, Volume 13, Issue 5 (2023) Health Topics: Health and disease ...
Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults
Verbrugghe, Mathieu; Van Loon, Nele; Dierick, Katelijne; Matagne, André; I Desombere; Ariën, Kevin K.; Marchant, Arnaud; Maria Goossens Source: Vaccine, Volume 41, Issue 17 (2023) Health Topics: Health and ...
Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial
I Desombere; Kevin K. Ariën; Maria Goossens Source: PLOS Global Public Health, Volume 2, Issue 12 (2022) Keywords: COVID-19; fractional dose; reduced dose; mRNA vaccination; non-inferiority; SARS-CoV-2 Abstract: ...
Humoral and cellular immune responses against SARS-CoV-2 after third dose BNT162b2 following double-dose vaccination with BNT162b2 versus ChAdOx1 in cancer patients.
Lisa Verheggen; Debbie Le Blon; Bart Peeters; Maria Goossens; Pieter Pannus; Ariën, Kevin K; Sébastien Anguille; Annelies Janssens; Hans Prenen; Evelien L J Smits; Christof Vulsteke; Eva Lion; Peeters, ...
Prevalence, incidence and longevity of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium: a prospective cohort study with 12 months of follow-up.
Den Bruel; I Desombere; Van Damme, Pierre; Goossens, Herman; Laëtitia Buret; Els Duysburgh; Coenen, Samuel Source: BMJ Open, Volume 12, Issue 9 (2022) Keywords: Adult Belgium COVID-19 Female Follow-Up ...
Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factors.
I Desombere; Sébastien Anguille; Zwi Berneman; Maria Goossens; Goossens, Herman; Surbhi Malhotra-Kumar; Evelina Tacconelli; Timon Vandamme; Peeters, Marc; Peter van Dam; Samir Kumar-Singh Source: Front Immunol, ...
Antibody response against SARS-CoV-2 Delta and Omicron variants after third-dose BNT162b2 vaccination in allo-HCT recipients.
Evelyne Willems; Grégory Ehx; Stanislas Goriely; Laurence Seidel; Johan Michiels; Betty Willems; Maria Goossens; Yves Beguin; Arnaud Marchant; Frédéric Baron Source: Cancer Cell, Volume 40, Issue 4 (2022) ...
Humoral and Cellular Immune Responses against SARS-CoV-2 after Third Dose BNT162b2 following Double-Dose Vaccination with BNT162b2 versus ChAdOx1 in Patients with CancerPurpose:Experimental Design:Results:Conclusions:
Marcq, Elly; Verheggen, Lisa; Le Blon, Debbie; Peeters, Bart; Maria Goossens; Pannus, Pieter; Ariën, Kevin K.; Anguille, Sébastien; Janssens, Annelies; Prenen, Hans; Smits, Evelien L.J.; Vulsteke, ...
Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant.
A Martens; Van Esbroeck, Marjan; Maria Goossens; Arnaud Marchant; Koen Bartholomeeusen; I Desombere Source: NPJ Vaccines, Volume 7, Issue 1 (2022) Abstract: We report the levels of neutralising antibodies ...
Hybrid immunity to SARS-CoV-2 in kidney transplant recipients and hemodialysis patients.
Publication Type: Peer reviewed scientific article Authors: Delphine Kemlin; Anne Lemy; Pieter Pannus; I Desombere; Nicolas Gemander; Maria Goossens; Arnaud Marchant; Le Moine, Alain Source: Am ...